OTHER
Therapeutics
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk of cardiac events
| The first 150 words of the full text of this article appear below. |
randomised controlled trial (Detection of Ischemia in Asymptomatic Diabetics [DIAD]). ClinicalTrials.gov NCT00769275 [ClinicalTrials.gov] .
concealed.*
blinded (outcome adjudication committee).*
14 centres in the USA and Canada.
1123 patients 50–75 years of age (mean age 61 y, 54% men) who had type 2 diabetes diagnosed at
30 years of age, no symptomatic or previously recognised coronary artery disease (CAD), and no history of ketoacidosis.
screening with adenosine-stress radionuclide myocardial perfusion imaging (MPI; n = 561) or no screening (n = 562). Screening results were provided to patients and their physicians; further diagnostic testing and treatment were done at their discretion.
primary outcome was a composite of non-fatal myocardial infarction and cardiac death. Secondary outcomes included unstable angina, heart failure, stroke, and coronary revascularisation. The trial had >80% power to detect a 20% relative difference in cardiac event rate with
= 0.05, based on an event rate of 5–10%.
median 5 years.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
